Holen Sie sich die Stockscreener-App
145.56
4.20%
5.87
Schlusskurs vom Vortag:
$139.69
Offen:
$139.53
24-Stunden-Volumen:
876.40K
Relative Volume:
1.64
Marktkapitalisierung:
$7.04B
Einnahmen:
$338.46M
Nettoeinkommen (Verlust:
$-310.96M
KGV:
-22.29
EPS:
-6.53
Netto-Cashflow:
$-132.82M
1W Leistung:
+5.63%
1M Leistung:
+13.77%
6M Leistung:
+35.37%
1J Leistung:
+56.23%
1-Tages-Spanne:
$138.90
$146.68
1-Wochen-Bereich:
$136.00
$146.68
52-Wochen-Spanne:
$75.56
$146.68
Axsome Therapeutics Inc Stock (AXSM) Company Profile
Firmenname
Axsome Therapeutics Inc
Sektor
Branche
Telefon
(212) 332-3241
Adresse
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Vergleichen Sie AXSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXSM
Axsome Therapeutics Inc
|
145.56 | 7.04B | 338.46M | -310.96M | -132.82M | -6.53 |
|
ARGX
Argen X Se Adr
|
929.61 | 55.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.02 | 110.91B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
197.40 | 41.21B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
376.63 | 40.48B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
704.31 | 72.89B | 14.25B | 4.58B | 3.88B | 41.77 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | B. Riley Securities | Buy |
| 2025-09-03 | Fortgesetzt | Wells Fargo | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-03 | Eingeleitet | Oppenheimer | Outperform |
| 2025-04-07 | Eingeleitet | Jefferies | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-12-31 | Bestätigt | Mizuho | Outperform |
| 2024-09-03 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-07-22 | Eingeleitet | Needham | Buy |
| 2024-04-29 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-03-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2024-01-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-12-13 | Eingeleitet | Citigroup | Buy |
| 2023-08-08 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-01-05 | Eingeleitet | Piper Sandler | Neutral |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2022-09-07 | Fortgesetzt | Mizuho | Buy |
| 2021-08-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-10 | Eingeleitet | Berenberg | Buy |
| 2021-01-08 | Eingeleitet | Jefferies | Buy |
| 2020-12-16 | Eingeleitet | Mizuho | Buy |
| 2020-09-29 | Eingeleitet | BofA Securities | Underperform |
| 2020-09-10 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-04-28 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-14 | Eingeleitet | Cowen | Outperform |
| 2019-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-12-17 | Bestätigt | H.C. Wainwright | Buy |
| 2019-12-16 | Bestätigt | Guggenheim | Buy |
| 2019-10-16 | Eingeleitet | Guggenheim | Buy |
| 2019-09-18 | Eingeleitet | William Blair | Outperform |
| 2019-05-28 | Eingeleitet | SunTrust | Buy |
| 2019-05-23 | Bestätigt | H.C. Wainwright | Buy |
| 2019-04-08 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-15 | Bestätigt | H.C. Wainwright | Buy |
| 2016-10-03 | Fortgesetzt | Brean Capital | Buy |
| 2015-12-15 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-12-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Axsome Therapeutics Inc Aktie (AXSM) Neueste Nachrichten
Axsome Therapeutics stock hits all-time high at 144.19 USD - Investing.com India
Axsome Therapeutics stock hits all-time high at 144.19 USD By Investing.com - Investing.com Australia
Will Axsome Therapeutics Inc. stock go up soonJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
Envestnet Asset Management Inc. Grows Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Bank of New York Mellon Corp Has $21.26 Million Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
How Axsome Therapeutics Inc. stock compares to industry benchmarksProfit Target & Fast Gaining Stock Strategy Reports - newser.com
Historical volatility pattern of Axsome Therapeutics Inc. visualizedWeekly Trend Report & Smart Swing Trading Alerts - newser.com
How Axsome Therapeutics Inc. stock performs in rate cut cyclesPortfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com
Axsome Therapeutics, Inc. $AXSM Shares Purchased by Los Angeles Capital Management LLC - MarketBeat
Candriam S.C.A. Trims Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Inc. stock momentum explainedEarnings Risk Report & Safe Entry Zone Identification - newser.com
(AXSM) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Tools to assess Axsome Therapeutics Inc.’s risk profileTrade Volume Summary & Daily Stock Trend Watchlist - newser.com
What Wall Street predicts for Axsome Therapeutics Inc. stock priceGap Up & Free Technical Confirmation Trade Alerts - newser.com
Can machine learning forecast Axsome Therapeutics Inc. recoveryJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com
How rising interest rates impact Axsome Therapeutics Inc. stock2025 Sector Review & Community Shared Stock Ideas - newser.com
Market reaction to Axsome Therapeutics Inc.’s recent newsInsider Selling & Low Risk High Win Rate Stock Picks - newser.com
Axsome Therapeutics Inc. recovery potential after sell offJuly 2025 Drop Watch & Community Shared Stock Ideas - newser.com
Why analysts recommend Axsome Therapeutics Inc. (19X) stock2025 Key Lessons & Daily Price Action Insights - Fundação Cultural do Pará
How Axsome Therapeutics Inc. (19X) stock reacts to Fed tighteningVolume Spike & Community Trade Idea Sharing - newser.com
Campbell & CO Investment Adviser LLC Purchases New Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Will Axsome Therapeutics Inc. stock sustain high P E ratios2025 Investor Takeaways & Daily Entry Point Trade Alerts - newser.com
How Axsome Therapeutics Inc. (19X) stock trades pre earningsM&A Rumor & Verified Swing Trading Watchlists - newser.com
Axsome Therapeutics (NASDAQ:AXSM) Hits New 12-Month HighWhat's Next? - MarketBeat
What candlestick patterns are forming on Axsome Therapeutics Inc.Gold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
Avenue Therapeutics Sells Baergic Bio to Axsome - TipRanks
RBC Capital Sticks to Their Buy Rating for Axsome Therapeutics (AXSM) - The Globe and Mail
Claim your share of the $7.75M Axsome Therapeutics securities class action settlement - Claim Depot
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Is Axsome Therapeutics Inc. stock a buy on dipsJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Axsome Therapeutics, Inc. Common StockAXSM - Markets Financial Content
Axsome Therapeutics acquires Baergic Bio from Avenue Therapeutics - MSN
2 Monster Stocks in the Making - Nasdaq
Connor Clark & Lunn Investment Management Ltd. Increases Stock Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Can Axsome Therapeutics Inc. stock continue upward trendJuly 2025 Retail & Advanced Technical Signal Analysis - newser.com
Why hedge funds are buying Axsome Therapeutics Inc. stockJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
Axsome Therapeutics Inc. stock trend forecastJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - newser.com
Is Axsome Therapeutics Inc. forming a reversal pattern2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
Axsome Therapeutics Eyes Baergic Bio: Is This the Next Big CNS Breakthrough? - Smartkarma
Finanzdaten der Axsome Therapeutics Inc-Aktie (AXSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.99%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):